Latest News about TCRR
Recent news which mentions TCRR
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
From Benzinga
The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics
December 13, 2020
From Benzinga
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
December 09, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 08, 2020
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 07, 2020
From Benzinga
The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted
November 18, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
November 17, 2020
From Benzinga
The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration
November 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 16, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
November 13, 2020
From Benzinga
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
November 13, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 09, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
November 04, 2020
From Benzinga
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
October 15, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
October 14, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
October 13, 2020
From Benzinga
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
October 13, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
October 12, 2020
From Benzinga
The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs
October 02, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
October 01, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 13, 2020
August 13, 2020
From Benzinga
4 Companies That Could Upend the Pharma Industry
July 29, 2020
From Motley Fool
From Benzinga
81 Biggest Movers From Yesterday
July 28, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC